Oxcarbazepine in a carbamazepine-intolerant patient with bipolar affective disorder: a case report.
Kalra
Harish
H
Inner City Mental Health Service, Royal Perth Hospital, Australia.
Dalal
Pronob K
PK
Allet
Lindsay
L
Janca
Aleksandar
A
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001714:Bipolar Disorder / Q000188:drug therapy*; D002220:Carbamazepine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D003875:Drug Eruptions / Q000209:etiology*; D004359:Drug Therapy, Combination; D005194:Family Practice; D005260:Female; D006801:Humans; D000078330:Oxcarbazepine; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use
D000927:Anticonvulsants; D018692:Antimanic Agents; D011619:Psychotropic Drugs; D002220:Carbamazepine; D000078330:Oxcarbazepine